ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag salary policy industry

Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
HHS Secretary Sullivan To Determine If NIH Gene Patent Quest Is Over
Scott Veggeberg | Oct 25, 1992 | 6 min read
The decision on whether the National Institutes of Health should continue its quest for patents on partial human cDNA sequences now rests with Health and Human Services secretary Louis Sullivan. In September, NIH director Bernadine Healy revealed that the agency had received an initial rejection from the United States Patent and Trademark Office (PTO) for the approximately 2,700 partial gene sequences generated by former NIH researcher Craig Venter and others. Then, on October 5, an HHS spok
U.S. Could Benefit Greatly From Aiding Ex-Soviet Scientists
Richard Eisner | Mar 29, 1992 | 8 min read
These individuals, and others like them, worked on classified military research. None favors nuclear proliferation, but each has the potential to make substantive scientific and engineering contributions to weapons programs in what have come to be known as the "rogue nations" of the world--Iraq, for example. But they also have the potential to contribute to the United States gross national product. Fortunately, they are in the U.S. at the moment, seeking productive employment in the research
Researchers Cope With The Increasing Cost Of Convening
Jeff Seiken | Apr 15, 1990 | 9 min read
While working toward his doctorate in 1973, plant geneticist Peter Gresshoff received an invitation to attend one of the meetings sponsored every summer by the Gordon Research Conferences. For Gresshoff, the mere fact that he was tapped to join the select group of 100 scientists participating in the conference constituted an honor in itself. Substantially more exciting, though, was the prospect of spending a week in close quarters with some of the top researchers in his field. The invitation c

Run a Search

ADVERTISEMENT